Dan Zimbroff

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder

The Journal of Clinical Psychiatry · 2002 · 488 citations

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

Neuropsychopharmacology · 1999 · 341 citations